This is a revised renewal application for a program projects grant entitled Excitatory Transmitters, Memory, Aging and Dementia (ETMAD), which has been funded for 4 years during which we have developed several strong lines of research that will serve as the foundation of this renewal proposal. A central theme of the proposal pertains to a neurodegenerative mechanism, NMDA receptor hypofunction (NRHypo), that we propose may play a key role in Alzheimer's disease (AD). A major emphasis of the proposed research is on testing certain tenets or predictions of the NRHYPO hypothesis. For example, we will induce an NRHYPO neurodegenerative reaction in the brains of transgenic mice to express beta amyloid to determine whether amyloidopathy and the NRHypo degenerative process interact to produce AD-like neuropathological changes and cognition deterioration. We will apply several approaches to address the question whether the neurodegenerative process in AD is mediated by an apoptotic mechanism, as many have proposed, or an excitotoxic mechanism, as our NRHYPO hypothesis proposes. We will explore preliminary evidence suggesting that estrogen may suppress NRHypo neurodegeneration, as it reportedly suppresses the neurodegenerative process in AD. We will follow up experiments to confirm our preliminary evidence to the NRHypo mechanism, and will conduct experiments to confirm our preliminary evidence that non-human primates are susceptible to the NRHypo neurodegenerative mechanism (an issue that currently is in dispute). The ultimate goal of these experiments is to develop a primate model for studying transmitter mechanisms potentially relevant to the pathophysiology of AD. To facilitate research in several projects pertaining to amyloidopathy or apoptosis we proposed to add a new core to the ETMAD program which will maintain a transgenic mouse facility to provide project leaders with transgenic or knockout mice that have genetic alterations relevant to the production or deposition of beta amyloid, or relevant to factors that promote or inhibit expression of apoptotic cell death. This new core facility will replace a prior immunobiology core that has served the ETMAD program well, but is no longer needed.
| Farber, Nuri B; Creeley, Catherine E; Olney, John W (2010) Alcohol-induced neuroapoptosis in the fetal macaque brain. Neurobiol Dis 40:200-6 |
| Creeley, Catherine E; Wozniak, David F; Nardi, Anthony et al. (2008) Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol Aging 29:153-67 |
| Wozniak, David F; Xiao, Maolei; Xu, Lin et al. (2007) Impaired spatial learning and defective theta burst induced LTP in mice lacking fibroblast growth factor 14. Neurobiol Dis 26:14-26 |
| Nikizad, H; Yon, J-H; Carter, L B et al. (2007) Early exposure to general anesthesia causes significant neuronal deletion in the developing rat brain. Ann N Y Acad Sci 1122:69-82 |
| Xiao, Maolei; Xu, Lin; Laezza, Fernanda et al. (2007) Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14. Mol Cell Neurosci 34:366-77 |
| Joksovic, Pavle M; Nelson, Michael T; Jevtovic-Todorovic, Vesna et al. (2006) CaV3.2 is the major molecular substrate for redox regulation of T-type Ca2+ channels in the rat and mouse thalamus. J Physiol 574:415-30 |
| Jevtovic-Todorovic, Vesna; Todorovic, Slobodan M (2006) The role of peripheral T-type calcium channels in pain transmission. Cell Calcium 40:197-203 |
| Todorovic, Slobodan M; Jevtovic-Todorovic, Vesna (2006) The role of T-type calcium channels in peripheral and central pain processing. CNS Neurol Disord Drug Targets 5:639-53 |
| Lu, Lucy X; Yon, Jun-Heum; Carter, Lisa B et al. (2006) General anesthesia activates BDNF-dependent neuroapoptosis in the developing rat brain. Apoptosis 11:1603-15 |
| Creeley, Catherine; Wozniak, David F; Labruyere, Joanne et al. (2006) Low doses of memantine disrupt memory in adult rats. J Neurosci 26:3923-32 |
Showing the most recent 10 out of 130 publications
